Navigation Links
IFHP Study Reveals Disparity In Medical Costs Around The Globe
Date:3/26/2013

NEW YORK, March 26, 2013 /PRNewswire/ -- The International Federation of Health Plans today released its 2012 Comparative Price Report, detailing its annual survey of medical costs per unit. Designed to showcase the variation in healthcare costs around the world, the report examines the price of medical procedures, tests, scans and treatments in 12 countries, as well as the costs of six widely-prescribed drugs. The survey data showed that the United States continues to have the highest prices of those countries surveyed for both medical procedures and drugs.

For example, the average cost for a hospital day is $429 in Argentina, $665 in South Africa and an average of $4,287 in the U.S. A diagnostic procedure such as a colonoscopy will cost from an average of $413 in Argentina to $893 in the United Kingdom and $1,185 in the United States. The survey also found that the cost of a widely prescribed drug for depression, Cymbalta, can range from $47 in the France to $176, the average cost in the U.S.

As in prior surveys, the differential between unit prices was greatest for surgical procedures. One of the highest differentials was for C-sections: The range ran from $1,541 in Argentina to an average of $15,041 in the United States.

IFHP will host a conference call and Webinar with Chief Executive Tom Sackville at 10 a.m. PDT / 1 p.m. EDT on Tues., March 26, to discuss the findings. Details for joining the conference call and Webinar follow at the end of this news release.

"With the cost and availability of healthcare being an important topic around the world, it's essential that we not only examine the disparities that exist, but also why and how certain gaps do exist," said IFHP's Sackville.

Costs examined in the study included those from Argentina, Australia, Canada, Chile, France, Germany, India, New Zealand, South Africa, Spain, Switzerland and the United States. The data for the report was gathered from IFHP member organizations in each country.  

The IFHP was founded in 1968 by a group of health fund industry leaders, and is now the leading global network of the industry, with nearly 100 member companies across 25 countries. IFHP aims to assist in the maintenance of high ethical and professional standards throughout the industry. 

For a copy of the report and more information about IFHP, please visit www.ifhp.com.

Following are details for the conference call and Webinar to discuss the report findings:WHO:Tom Sackville, CEO of IFHPWHEN: 

Tuesday, March 2610 a.m. PDT/ 1 p.m. EDTWHERE: 

Remarks and Q&A session via conference call at (866) 901-4714 (U.S. and Canadian callers)(702) 599-4277 (callers outside United States and Canada)Conference ID: 26726254See the presentation online at: 

https://www.livemeeting.com/cc/edelman/join?id=FFMMB2&role=attend&pw=T%2F%7E5dhp
Meeting ID: FFMMB2
Entry Code: T/~5dhp

First Time Users:
To save time before the meeting, check your system to make sure it is ready to use Microsoft Office Live Meeting.

Troubleshooting
Unable to join the meeting? Follow these steps:

1.

Copy this address and paste it into your web browser: https://www.livemeeting.com/cc/edelman/join 2.

Copy and paste the required information: Meeting ID: FFMMB2Entry Code: T/~5dhpLocation: https://www.livemeeting.com/cc/edelman


'/>"/>
SOURCE International Federation of Health Plans
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
3. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
4. New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
5. Shingles Vaccine is Safe, According to New Study
6. Structural Trends to Profoundly Change Life Sciences Industry, Genpact Study Shows
7. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
8. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
9. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
10. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
11. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... 23. Januar 2017  ResMed (NYSE: RMD ... 3B Medical ( Winter Haven, Florida ) ... über die Beilegung aller globalen Rechtsstreitigkeiten zwischen den Parteien ... ihrer bestehenden Produkte im Tausch gegen Lizenzgebühren an ... 3B leisten, um das in Florida ...
(Date:1/23/2017)... Jan. 23, 2017 Just two weeks remain until legal experts ... gather in Central London to discuss the flow ... in the market, Parallel Trade 2017 . In the ... of attendees which is available to read in the event download ... Some of ...
(Date:1/21/2017)... According to a new market research report "Life Science ... Component (Software, Service), Delivery (On premise, Cloud), End user (Pharmaceutical, Biotechnology, ... market is expected to reach USD 24.73 Billion by 2021 from ... the forecast period. Continue Reading ... ...
Breaking Medicine Technology:
(Date:1/22/2017)... ... January 22, 2017 , ... Zifam Pinnacle, an Australian company ... recently met with big-name retail buyers at the January ECRM Trade Show in Hilton ... uses the utmost safety standards in all of its creations to help create a ...
(Date:1/22/2017)... ... January 22, 2017 , ... Medical lab testing through hospitals and ... a simple test will take days to arrive to the end customer, having to ... access to their lab tests, bypassing the cost and delay of traditional means. Now ...
(Date:1/21/2017)... ... January 21, 2017 , ... Salveo for life, a company that ... product to the United States as part of its presence to expand its market ... aims to reduce the productions of nasty toxins as a result of drinking alcohol, ...
(Date:1/21/2017)... ... ... Seamild, the largest manufacturer of oats in China, is now aiming at global business ... recognized globally as one of the healthiest cereals, XieQingkui, the founder of Seamild, strongly ... to sow the seed of good karma. Buddhism spirit featuring benevolence and sacrifice are ...
(Date:1/21/2017)... ... January 21, 2017 , ... Pacifica Graduate Institute’s Alumni ... line-up of events for its annual meeting “Coming Home 2017,” an activity-packed weekend ... Home 2017” will be held on Friday January 27 through Sunday, January 29, ...
Breaking Medicine News(10 mins):